Cargando…
High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis
BACKGROUND: Soluble CD40 ligand (sCD40L) and matrix metalloproteinase 9 (MMP-9) are inflammation markers and have been poorly described in infectious disease. In this prospective study, we describe the sera kinetics of these two molecules in the course of treatment follow up in human visceral leishm...
Autores principales: | de Oliveira, Fabrícia Alvisi, Vanessa Oliveira Silva, Carla, Damascena, Nayra Prata, Passos, Rodrigo Oliveira, Duthie, Malcolm S, Guderian, Jeffrey A, Bhatia, Ajay, de Moura, Tatiana Rodrigues, Reed, Steven G, de Almeida, Roque Pacheco, de Jesus, Amélia Ribeiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733913/ https://www.ncbi.nlm.nih.gov/pubmed/23870715 http://dx.doi.org/10.1186/1471-2334-13-331 |
Ejemplares similares
-
Use of N-acetylcysteine as treatment adjuvant regulates immune response in visceral leishmaniasis: Pilot clinical trial and in vitro experiments
por: Magalhães, Lucas Sousa, et al.
Publicado: (2022) -
The Severity of Visceral Leishmaniasis Correlates with Elevated Levels of Serum IL-6, IL-27 and sCD14
por: dos Santos, Priscila L., et al.
Publicado: (2016) -
Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis
por: Barbosa Santos, Micheli Luize, et al.
Publicado: (2017) -
Soluble CD40 Ligand in Sera of Subjects Exposed to Leishmania infantum Infection Reduces the Parasite Load in Macrophages
por: de Oliveira, Fabrícia Alvisi, et al.
Publicado: (2015) -
Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis
por: Duthie, Malcolm S., et al.
Publicado: (2016)